SCHEDULE: AdvisorShares Trust Discloses 1.66% Stake in Enveric Biosciences
Beneficial Ownership Report
AdvisorShares Trust has reported a 1.66% beneficial ownership stake in Enveric Biosciences, Inc., holding 16,974 shares of common stock.
Summary
- AdvisorShares Trust, a Delaware-organized entity, has filed a Schedule 13G indicating beneficial ownership in Enveric Biosciences, Inc.
- The filing reports ownership of 16,974 shares of Enveric Biosciences' Common Stock, $0.01 par value.
- This stake represents 1.66% of the class of securities.
- AdvisorShares Trust holds sole voting power and sole dispositive power over all 16,974 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership, which is neutral in sentiment regarding the company's operational or financial performance. It indicates institutional interest but provides no further insights into the company's prospects.
Positives
- An institutional investor, AdvisorShares Trust, has disclosed a stake in Enveric Biosciences, which can be viewed as a vote of confidence or increased institutional interest.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or operations.
Industry Context
This filing represents a standard disclosure of passive institutional ownership, common in the investment industry. AdvisorShares Trust operates as an investment company, and such filings are routine for entities managing portfolios that cross beneficial ownership thresholds.
Stakeholder Impact
- Shareholders may view the disclosure of institutional ownership by AdvisorShares Trust as a minor positive, potentially indicating increased investor confidence or liquidity in Enveric Biosciences' stock.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires filing of this statement (end of reporting period) |
| 01/05/2026 | Date of filing and signature by Chief Compliance Officer |
Keywords
Enveric Biosciences, AdvisorShares Trust, Common Stock, SEC Filing, Schedule 13G, Institutional Ownership, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.